Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
44
CVKD Quote, Financials, Valuation and Earnings
Last price:
$9.90
Seasonality move
:
23.77%
Day range:
$9.84 - $11.04
52-week range:
$8.12 - $22.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
7.73x
Volume:
38.4K
Avg. volume:
26.2K
1-year change:
-23.86%
Market cap:
$21.1M
Revenue:
--
EPS (TTM):
-$8.01
Earnings Data
Next earnings date for CVKD
--
Most recent earnings per share
-$1.31
Beat by $0.24
(Nov 28/2025)
Consensus Estimate
-$1.55
(Nov 28/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CVKD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | -- | -- | -- | -$1.21 | -- |
| 11/28/2025 | Q3 | -- | -- | -$1.31 | -$1.55 | $0.24 |
| 08/11/2025 | Q2 | -- | -- | -$1.87 | -$1.78 | -$0.09 |
| 05/08/2025 | Q1 | -- | -- | -$2.09 | -$2.15 | $0.06 |
| 03/13/2025 | Q4 | -- | -- | -$2.75 | -$1.87 | -$0.88 |
| 09/30/2024 | Q3 | -- | -- | -$2.18 | -$1.80 | -$0.38 |
| 06/30/2024 | Q2 | -- | -- | -$2.24 | -$1.80 | -$0.44 |
| 03/31/2024 | Q1 | -- | -- | -$1.56 | -$1.35 | -$0.21 |
| 12/31/2023 | Q4 | -- | -- | -$1.32 | -$1.35 | $0.03 |
| 09/30/2023 | Q3 | -- | -- | -$1.19 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$1.28 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$6.62 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$6.46 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$1.32 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.98 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.23 | -- | -- |
Cadrenal Therapeutics, Inc. Earnings Questions
-
How Much did Cadrenal Therapeutics, Inc. Generate in Revenue Last Quarter?
Cadrenal Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Cadrenal Therapeutics, Inc. Beat Earnings Last Quarter?
Cadrenal Therapeutics, Inc. announced earnings per share of -$1.31 which represents a beat of analyst forecast a -$1.55 per share.
-
Is Cadrenal Therapeutics, Inc. Profitable?
Cadrenal Therapeutics, Inc. reported -$400 that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Cadrenal Therapeutics, Inc. EPS Next Year?
Cadrenal Therapeutics, Inc.'s earnings are forecast to decrease from -$8.73 per share to -$7.80 per share next year representing a decrease of -27.07%.
-
When is Cadrenal Therapeutics, Inc.'s Earnings Date?
Currently, Cadrenal Therapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 10, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Buy
72
KYMR alert for Dec 8
Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.
